ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Psychogeriatrics

Psychogeriatrics

Volume 3 Issue 1, Pages 39 - 44

Published Online: 6 May 2003

Journal compilation © 2009 The Japanese Psychogeriatric Society



< Previous Abstract

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 152K)  | Related Articles | Citation Tracking

CASE REPORT
Effects of low-dose quetiapine on psychotic symptoms in elderly patients with physical illnesses: Report of eight cases
Hideyuki Hattori , Masayuki Matsumoto , Shigeto Morimoto , Kunimitu Iwai , Hiroshi Tsuchiya , Eiji Miyauchi , Mikihiro Takasaki , Tsuyoshi Nakahashi , Kohya Okaishi , Hiroshi Murai , Yukiharu Nishimura , Yuhki Owari , Kohji Nomura , Shozaburo Kato and Ling Yu Kong
  Department of Geriatric Medicine, Kanazawa Medical University, Ishikawa, Japan
Correspondence: Dr Hideyuki Hattori, PhD, Department of Geriatric Medicine, Kanazawa Medical University, Daigaku 1-1, Uchinada-Machi, Kahoku-Gun, Ishikawa 920-0293, Japan. Email: hideyuki@kanazawa-med.ac.jp
Copyright 2003 Japanese Psychogeriatric Society
KEYWORDS
delirium • elderly • hallucination • quetiapine

ABSTRACT

Quetiapine, which is a new atypical antipsychotic agent, was administered at low doses (25–50 mg/day) for psychotic symptoms in eight elderly patients with physical illnesses. Delirium and hallucination were alleviated by the administration of low doses of quetiapine, and the cause–effect relationship between the administration and alleviation of symptoms was evident, particularly in one patient with delirium, because delirium was alleviated after administration began, was exacerbated after discontinuation of quetiapine, and was alleviated again after administration was resumed. Little improvement was observed in delusions or mood disorders. None of the patients showed exacerbation of physical symptoms or abnormalities in clinical laboratory tests. The results of this study suggest that quetiapine might be effective in reducing delirium and hallucination that often accompany physical illness in elderly people and could be used without adverse effects.


Received 7 November 2002; accepted 24 December 2002.

DIGITAL OBJECT IDENTIFIER (DOI)
10.1046/j.1479-8301.2003.00005.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now